An overview of changing aspects for national Phase I trials under the EU Clinical Trial Regulation (13 MAY 2022)
The supporting presentations for each of the Session Leads
Ingrid Klingmann – Introduction
1. Ingrid Klingmann_Introduction.pdf
Sebastien Vanhiesbecq – CT College BE
2.1 Sebastien Vanhiesbecq_CT College_BE